<\/p>\n
Anaridex<\/strong> er en tablett fra Cipla som inneholder anastrozole 1 mg<\/strong> \u2014 en selektiv third-generation aromatase inhibitor<\/strong>. First-line adjuvant and metastatic therapy for hormone-receptor-positive breast cancer in postmenopausal women<\/strong>. Standard dose: 1 mg en gang daglig<\/strong>, typically for 5–10 years<\/strong> in adjuvant setting. Anastrozole works by blocking conversion of androgens to oestrogen in peripheral tissue (~95% suppression). Postmenopausal women only<\/strong> — ineffective in premenopausal women (use tamoxifen<\/a> instead). Main side effects: hot flushes, joint and muscle pain (arthralgia in 30%), bone-density loss with fracture risk, vaginal dryness, mood change. Mandatory: baseline DEXA scan + repeat every 2 years; calcium + vitamin D supplementation; consider bisphosphonate or denosumab if osteopenia.<\/p>\n<\/div>\n \ud83d\udce6 Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis pakken din ikke ankommer innen 20 virkedager, sender vi ny.<\/p>\n Anaridex is an oral tablet from Cipla containing anastrozole 1 mg<\/strong>. Anastrozole is a third-generation, non-steroidal, selective aromatase inhibitor used for adjuvant and metastatic treatment of hormone-receptor-positive (HR+) breast cancer in postmenopausal women<\/strong>. Originally developed by AstraZeneca (brand name Arimidex), anastrozole is now a generic standard of care. It is one of the three most-prescribed aromatase inhibitors worldwide alongside exemestane<\/a> og letrozole<\/a>.<\/p>\n In postmenopausal women, ovarian oestrogen production has stopped — circulating oestrogen comes almost entirely from peripheral conversion of adrenal and gonadal androgens (androstenedione, testosterone) by the enzyme aromatase<\/strong> in fat, muscle, liver and breast tissue. Anastrozole reversibly inhibits aromatase, suppressing peripheral oestrogen synthesis by approximately 95%<\/strong> within 24–48 hours.<\/p>\n Anaridex is ikke<\/strong> indicated for: premenopausal women (use tamoxifen, or AI + ovarian suppression under specialist guidance), HR-negative breast cancer (no benefit), or non-cancer cosmetic indications.<\/p>\n Standard dose: 1 mg en gang daglig<\/strong>. Typical course length:<\/p>\n Common (oestrogen-deprivation symptoms):<\/strong><\/p>\n Important long-term:<\/strong><\/p>\n Less common but seek review:<\/strong><\/p>\nWhat Is Anaridex?<\/h2>\n
How Does Anaridex Work?<\/h2>\n
\n
Bruk og indikasjoner<\/h2>\n
\n
Anaridex Dosage and How to Take<\/h2>\n
\n
How to Take Anaridex Properly<\/h3>\n
\n
Side Effects of Anaridex<\/h2>\n
\n
\n
\n
Advarsler og forholdsregler<\/h2>\n
\n
Legemiddelinteraksjoner<\/h2>\n